Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$ 81,944	$ 65,284
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	2,431	2,647
Amortization of intangible assets	548	666
Deferred income tax expense	3,320	5,523
Provision for credit losses	6,598	10,913
Stock-based compensation expense	3,954	3,425
Net amortization on loan fees, costs, premiums, and discounts	1,980	238
Net amortization (accretion) on securities premiums, discounts, and deferred costs on subordinated debt	(182)	1,546
Net loss (gain) from equity method investments	301	(1,261)
Net loss on sale of securities available for sale	8,695	5,052
Net loss (gain) on sale of loans and change in fair value on loans held-for-sale, net	4,107	(30)
Net gain on redemption of bank-owned life insurance	0	(371)
Proceeds from sales of loans held for sale	16,384	15,829
Originations of loans held for sale	(16,441)	(12,962)
Increase in cash surrender value of bank-owned life insurance	(1,837)	(1,683)
Net gain on repurchase of subordinated debt	(1,076)	(1,417)
Decrease (increase) in accrued interest receivable	1,216	(6,304)
Decrease in other assets	387	16,625
Decrease in other liabilities	(17,270)	(1,813)
Net cash provided by operating activities	95,059	101,907
CASH FLOWS FROM INVESTING ACTIVITIES
Net increase in loans	(191,200)	(264,555)
Purchase of securities available for sale	(738,851)	(69,382)
Purchase of securities held-to-maturity	(54,547)	(211,211)
Proceeds from sales of securities available for sale	271,033	249,971
Maturities, principal payments and redemptions of securities available for sale	226,916	123,175
Maturities, principal payments and redemptions of securities held-to-maturity	140,353	70,100
Decrease (increase) in resell agreements	(24,883)	25,754
Decrease (increase) in equity method investments	1,209	(2,247)
Decrease (increase) in FHLBNY stock, net	(236)	25,218
Purchases of premises and equipment, net	(1,037)	(1,219)
Proceeds from redemption of bank-owned life insurance	0	1,941
Net cash used in investing activities	(371,243)	(52,455)
CASH FLOWS FROM FINANCING ACTIVITIES
Net increase in deposits	582,576	395,817
Net decrease in other borrowings	(229,627)	(345,619)
Repurchase of subordinated debt	(5,925)	(6,047)
Common stock issued under Employee Stock Purchase Plan	632	650
Repurchase of common stock	(285)	(7,229)
Dividends paid	(10,550)	(9,277)
Payments related to repurchase of common stock for equity awards	(2,000)	(1,068)
Net cash provided by financing activities	334,821	27,227
Increase in cash, cash equivalents, and restricted cash	58,637	76,679
Cash, cash equivalents, and restricted cash at beginning of year	90,570	63,540
Cash, cash equivalents, and restricted cash at end period	149,207	140,219
Supplemental disclosures of cash flow information:
Interest paid during the period	97,613	59,104
Income taxes paid during the period	27,724	7,381
Right-of-use assets obtained in exchange for lease liabilities	560	0
Loans transferred from held-for-sale	0	4,664
Loans transferred to held-for-sale	$ 40,856	$ 3,581